Bioreactor– tag –
-
Bioreactor-Based Transient Transfection with HEK 293-F Cells Unlocks Large-Scale HPV VLP Production
MDPI Switzerland Overview A recent study demonstrates a significant advance in biopharmaceutical manufacturing, achieving highly efficient, large-scale production of HPV16 L1/L2 chimeric virus-like particles (VLPs). By leveraging transie... -
Chime Biologics Unveils AI-Driven Biomanufacturing Future with New Wuhan GMP-2 Facility and 100+ Bioreactor Megafactory Vision
BioPharma APAC China Overview Chime Biologics has significantly bolstered its biopharmaceutical manufacturing capabilities with the opening of its GMP-2 facility in Wuhan, China, equipped with eight Cytiva 2,000-liter single-use Xcellere... -
Gene Therapy’s Production Puzzle: Why AAV Outscales Lentiviral Vectors in Large-Scale Manufacturing
Industry Analysis USA Overview A recent analysis comparing AAV and lentiviral vector manufacturing platforms, both produced via transient transfection of HEK293 cells, reveals critical downstream manufacturing distinctions. AAV's stable ... -
AGC Biologics Commits Half of New Yokohama Biomanufacturing Plant to Major Long-Term Deal
Megaproject Japan Overview AGC Biologics has secured a significant multi-million dollar, long-term commercial manufacturing contract with an undisclosed pharmaceutical firm for its new Yokohama facility, set to open in 2027. This landmar... -
AAV Vector Manufacturing Achieves Kilo-Scale Production with 2,000L+ Suspension Bioreactors, Solving Gene Therapy Bottleneck
Drug Discovery News USA Overview AAV upstream production has achieved significant scalability, with suspension bioreactors reaching over 2,000 liters using adapted HEK293 cells, providing volumetric capacity for clinical and commercial g... -
Cell Therapy Clinical Success Hinges on Manufacturability: Limitations of Autologous Therapies Drive Interest in Allogeneic ‘Off-the-Shelf’ Platforms
Cell & Gene Unknown Overview Cell therapy scalability is a critical factor to consider from early development, as autologous therapies face challenges in manufacturing complexity, scheduling constraints, and inherent scalability limitati... -
Liv Hospital Accelerates iPSC Therapy with Bioreactor Investment, Targeting Parkinson’s Disease
Liv Hospital Turkey Overview Liv Hospital is addressing the critical challenge of safe and efficient mass production of induced pluripotent stem cells (iPSCs) through a major investment in advanced bioreactor systems. This initiative aim... -
Sartorius Unveils AI-Enabled Ambr 250 HT and Pionic Platform, Sustains Strong H1 2026 Business Growth and Profitability
boerse.de Germany Overview Sartorius Stedim Biotech has expanded its solution portfolio with the launch of the AI-enabled Ambr 250 HT Cell Therapies Vessel and the Pionic platform for intensified continuous bioprocessing. These innovatio... -
Sartorius Stedim Ambr 15 24-Vessel Microbioreactor System Accelerates Microbial Fermentation Development with Integrated High-Throughput Analysis Module
Boston Industries USA Overview The Sartorius Stedim Ambr 15 Microbioreactor System enables high-throughput, parallel bioprocess development for microbial fermentation studies, featuring 24 disposable stirred-tank vessels with an integrat... -
PBS Biotech Joins Organoid COMMONS with Vertical-Wheel® Bioreactor to Accelerate Industrialization and Scalability of Human Organoid Models
PR Newswire (PBS Biotech) USA Overview PBS Biotech has joined Organoid COMMONS to accelerate the industrialization and scalability of human-relevant organoid models. The company contributes its unique Vertical-Wheel® bioreactor platform ...
